Joseph Gold

Joe joined Catamaran as Vice President, Technical Operations and Manufacturing, in August 2021. He brings more than twenty-five years of experience in cell therapy development and GMP manufacturing of cell and gene therapies. Prior to Catamaran, Joe served as Senior Director, Manufacturing at City of Hope’s Center for Biomedicine and Genetics where he led viral vector and cell therapy process development and GMP manufacturing for oncology and regenerative medicine projects for City of Hope clinical trials and external clients. Before his role at the City of Hope, he worked at Stanford’s Cardiovascular Institute as Assistant Director of Translational Research, working to bring stem cell-derived therapies for heart failure to the clinic. Joe began his career in biotechnology at Geron Corporation, where he headed up basic research into pluripotent stem cell-derived therapies for diseases ranging from spinal cord injury to diabetes to heart failure. Joe performed his postdoctoral research at UCSF in early embryological development. He holds a PhD in Cell and Developmental Biology from Harvard and a BS in Biology from the University of Pennsylvania.